ARTICLE | Clinical News
Sepsis genetic marker regulatory update
February 26, 2001 8:00 AM UTC
ILGN received notice of allowance for a U.S. patent covering variations in the IL-1B gene, which the company said are associated with an increased risk of dying from sepsis. ...